ATE258054T1 - 4-aryl-3-hydroxychinolin-2-on-derivate als modulatoren des ionenkanals - Google Patents

4-aryl-3-hydroxychinolin-2-on-derivate als modulatoren des ionenkanals

Info

Publication number
ATE258054T1
ATE258054T1 AT97949482T AT97949482T ATE258054T1 AT E258054 T1 ATE258054 T1 AT E258054T1 AT 97949482 T AT97949482 T AT 97949482T AT 97949482 T AT97949482 T AT 97949482T AT E258054 T1 ATE258054 T1 AT E258054T1
Authority
AT
Austria
Prior art keywords
hydroxyquinoline
aryl
derivatives
ion channel
channel modulators
Prior art date
Application number
AT97949482T
Other languages
English (en)
Inventor
Sing-Yuen Sit
Nicholas A Meanwell
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE258054T1 publication Critical patent/ATE258054T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT97949482T 1996-11-26 1997-11-18 4-aryl-3-hydroxychinolin-2-on-derivate als modulatoren des ionenkanals ATE258054T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3110596P 1996-11-26 1996-11-26
PCT/US1997/021136 WO1998023273A1 (en) 1996-11-26 1997-11-18 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators

Publications (1)

Publication Number Publication Date
ATE258054T1 true ATE258054T1 (de) 2004-02-15

Family

ID=21857682

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97949482T ATE258054T1 (de) 1996-11-26 1997-11-18 4-aryl-3-hydroxychinolin-2-on-derivate als modulatoren des ionenkanals

Country Status (11)

Country Link
US (2) US5892045A (de)
EP (1) EP0942723B1 (de)
JP (1) JP2002508740A (de)
AR (1) AR010306A1 (de)
AT (1) ATE258054T1 (de)
CA (1) CA2266605A1 (de)
DE (1) DE69727312T2 (de)
ES (1) ES2214644T3 (de)
TW (1) TW504504B (de)
WO (1) WO1998023273A1 (de)
ZA (1) ZA9710561B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2341318A (en) * 1998-09-14 2000-03-15 Boehringer Ingelheim Pharma A Dihydroisoquinoline (LOE 908) and Traumatic Brain Injury.
DE69935245T2 (de) * 1998-12-04 2007-10-31 Bristol-Myers Squibb Co. 3-substituierte-4-arylchinolin-2-on derivate als kaliumkanal- modulatoren
GB9915414D0 (en) * 1999-07-01 1999-09-01 Glaxo Group Ltd Medical use
TW562799B (en) 1999-12-01 2003-11-21 Bristol Myers Squibb Co Preparation of 3-substituted-4-arylquinolin-2-one derivatives
US20050153940A1 (en) * 2000-01-26 2005-07-14 Cedars-Sinai Medical Center Method for using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumor
US7018979B1 (en) 2000-01-26 2006-03-28 Cedars-Sinai Medical Center Method for using potassium channel agonists for delivering a medicant to an abnormal brain region and/or a malignant tumor
EP1330426A4 (de) * 2000-10-13 2005-09-14 Bristol Myers Squibb Co Selektive maxi-k-kaliumkanalöffner, die unter bedingungen hoher intrazellulärer kalziumkonzentrationen wirken, verfahren und deren verwendung
US7211561B2 (en) * 2001-10-12 2007-05-01 Cedars-Sinai Medical Center Method for inducing selective cell death of malignant cells by activation of calcium-activated potassium channels (KCa)
GB0212971D0 (en) * 2002-06-06 2002-07-17 Karobio Ab Novel compounds
US6939968B2 (en) 2002-12-23 2005-09-06 Bristol-Myers Squibb Company Atropisomers of 3-substituted-4-arylquinolin-2-one derivatives
US7179920B2 (en) * 2003-10-14 2007-02-20 Bristol-Myers Squibb Company 3-thia-4-arylquinolin-2-one derivatives
US7049309B2 (en) * 2003-10-14 2006-05-23 Bristol-Myers Squibb Company 3-Thia-4-arylquinolin-2-one potassium channel modulators
US7132542B2 (en) 2003-10-14 2006-11-07 Bristol-Myers Squibb Company Compounds for the treatment of male erectile dysfunction
US7151180B2 (en) * 2003-10-14 2006-12-19 Bristol-Myers Squibb Company Potassium channel modulators
US7002015B2 (en) * 2003-10-14 2006-02-21 Bristol-Myers Squibb Company 3-Thia-4-arylquinolin-2-one derivatives as smooth muscle relaxants
US7145013B2 (en) * 2003-10-14 2006-12-05 Bristol-Myers Squibb Company 3-thia-4-arylquinolin-2-one derivatives
WO2006091542A2 (en) * 2005-02-22 2006-08-31 Cedars-Sinai Medical Center Use of sildenafil, vardenafil and other 5-phosphodiesterase inhibitors to enhance permeability of the abnormal blood-brain barrier
AU2006216629A1 (en) * 2005-02-24 2006-08-31 Janssen Pharmaceutica N.V. Novel quinoline derivatives as potassium ion channel openers
WO2021252681A1 (en) * 2020-06-10 2021-12-16 Ideaya Biosciences, Inc. Quinolinone derivatives as methionine adenosyltransferase 2a inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3202661A (en) * 1962-11-27 1965-08-24 Hoffmann La Roche Substituted 3-amino 4-phenyl quinolones
US5200422A (en) * 1990-09-24 1993-04-06 Neurosearch A/S Benzimidazole derivatives, their preparation and use
NZ239540A (en) * 1990-09-24 1993-11-25 Neurosearch As 1-phenyl benzimidazole derivatives and medicaments
US5234947A (en) * 1991-11-07 1993-08-10 New York University Potassium channel activating compounds and methods of use thereof
US5565483A (en) * 1995-06-07 1996-10-15 Bristol-Myers Squibb Company 3-substituted oxindole derivatives as potassium channel modulators

Also Published As

Publication number Publication date
US5922735A (en) 1999-07-13
DE69727312T2 (de) 2004-11-18
TW504504B (en) 2002-10-01
EP0942723A1 (de) 1999-09-22
CA2266605A1 (en) 1998-06-04
EP0942723B1 (de) 2004-01-21
ES2214644T3 (es) 2004-09-16
EP0942723A4 (de) 2002-05-15
WO1998023273A1 (en) 1998-06-04
JP2002508740A (ja) 2002-03-19
US5892045A (en) 1999-04-06
AU7408598A (en) 1998-06-22
DE69727312D1 (de) 2004-02-26
AR010306A1 (es) 2000-06-07
AU716832B2 (en) 2000-03-09
ZA9710561B (en) 1999-05-24

Similar Documents

Publication Publication Date Title
ATE195515T1 (de) 3-substituierte oxindolderivate als kaliumkanalmodulatoren
ATE354569T1 (de) 3-substituierte-4-arylchinolin-2-on derivate als kaliumkanal- modulatoren
ATE258054T1 (de) 4-aryl-3-hydroxychinolin-2-on-derivate als modulatoren des ionenkanals
FI964298A0 (fi) Faestningsanordning foer baerbar apparat
DE69732364D1 (de) Ionenquelle
DE59706144D1 (de) Ausrichtvorrichtung
FI951910A (fi) Ioniliikespektrometri
DE69705112T2 (de) Coralynanaloge als topoisomerase inhibitoren
PT891332E (pt) Derivados de 6-fenilpiridil-2-amina
DE69806141D1 (de) Indazoleamid-verbindungen als serotoninergene mittel
BR9709065A (pt) Derivados de alquilaminobenzotiazole e-benzoxazol
BR9703909A (pt) Formador de blocos
BR9711891A (pt) Elast-meros de spandex aperfei-oados
PT923594E (pt) Compostos de bromotiacumicina
PT906279E (pt) Derivados de pirrol
DE9416319U1 (de) Kanalsystem
MD665F1 (ro) Rachiu Vodka
DE59705650D1 (de) Mehrkanalsystem-Gehäuse
DE29718615U1 (de) Kanaleinheit
ID17345A (id) Metode yang disempurnakan untuk mengendalikan rayap
DE29602795U1 (de) Lichtkanal
BR9708310A (pt) Derivados de 2-tioxotetrahidropirimidin-4-ona
BR9706980A (pt) Derivados de isooxacefem
DE69617417D1 (de) Einfach-Potential Ionenquelle
AU8010598A (en) Device for gate poles

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0942723

Country of ref document: EP

REN Ceased due to non-payment of the annual fee